Stock market today: Relmada Therapeutics declined by 74.74% while Cyclerion Therapeutics saw surge of 392.22% in early trading
Relmada Therapeutics, Inc. reported a decline of 74.74%, with its stock priced at 0.70 USD and a market capitalization of 83.58 M USD.